Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? : Journal of Cardiovascular Medicine

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Research letters

Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?

Tini, Giacomoa,b,c; Sarocchi, Matteoc; Ameri, Pietrob,c; Tocci, Giulianoa; Battistoni, Allegraa; Arboscello, Eleonorad; Spallarossa, Paoloc; Porto, Italob,c

Author Information
Journal of Cardiovascular Medicine: December 2022 - Volume 23 - Issue 12 - p 809-810
doi: 10.2459/JCM.0000000000001346
  • Buy
© 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.